Maternal-Newborn and Reproductive Health Review

Obstetric Complications and High-Risk Conditions

  • Placenta Previa versus Placental Abruption (Abruptio Placentae):

    • Placenta Previa: Occurs when the placenta implants improperly in the lower uterine segment, encroaching upon or completely covering the internal cervical os.

    • Abruptio Placentae (Placental Abruption): Involves the premature separation and detachment of a normally situated placenta from the decidual lining of the uterine wall prior to delivery.

    • Diagnostic Modality: An abdominal or transvaginal ultrasound is the definitive diagnostic imaging tool used to visualize placental location and differentiate between previa and abruption.

  • Hypertensive Disorders of Pregnancy:

    • Preeclampsia: A pregnancy-specific systemic syndrome characterized by new-onset hypertension and proteinuria or end-organ dysfunction after 20 weeks20\text{ weeks} of gestation.

    • Eclampsia: The progression of preeclampsia defined by the onset of grand mal seizures or unexplained coma in a preeclamptic client, unrelated to other cerebral conditions.

    • Clinical Implications for Delivery: Preeclampsia is a strict contraindication for home birth due to the high risk of rapid clinical deterioration, progression to eclampsia, and severe maternal-fetal morbidity.

  • HELLP Syndrome:

    • A severe obstetric complication, often considered a variant or progression of severe preeclampsia, defined by its laboratory triad:

      • H: Hemolysis (microangiopathic hemolytic anemia).

      • EL: Elevated Liver enzymes (transaminitis reflecting hepatic ischemia or injury).

      • LP: Low Platelet count (thrombocytopenia due to widespread platelet aggregation and consumption, with levels falling below 100,000/μL100{,}000/\mu\text{L}).

    • Critical knowledge of this condition is required for all healthcare staff practicing in labor and delivery environments.

  • Rh Incompatibility and Alloimmunization:

    • Pathophysiology: Develops when an Rh-negative mother carries an Rh-positive fetus. If fetal Rh-positive red blood cells enter maternal circulation, the maternal immune system recognizes the foreign Rh(D) antigen and produces anti-D immunoglobulins (antibodies).

    • Sensitization and Subsequent Pregnancies: The first Rh-positive pregnancy is typically unaffected because antibody titers take time to rise. In subsequent Rh-positive pregnancies, maternal IgG antibodies cross the placenta, bind to fetal erythrocytes, and trigger severe hemolytic destruction, resulting in hydrops fetalis, severe fetal anemia, and intrauterine fetal demise.

    • Prophylaxis with RhoGAM (Rh_o(D) Immune Globulin):

      • RhoGAM prevents maternal antibody formation by clearing fetal Rh-positive erythrocytes from maternal blood before an immune response can be mounted.

      • Administered routinely at the 7th month7\text{th}\text{ month} (28 weeks28\text{ weeks}) of gestation to all unsensitized Rh-negative pregnant women.

      • Administered postpartum within 72 hours72\text{ hours} of delivery if cord blood testing confirms the newborn is Rh-positive.

      • If the infant is confirmed Rh-negative at delivery, maternal administration of postpartum RhoGAM is unnecessary because no foreign Rh antigen is present.

      • If the mother is Rh-positive, Rh incompatibility is impossible, regardless of the baby's Rh status.

  • Gestational Diabetes and Fetal Macrosomia:

    • Maternal hyperglycemia results in fetal hyperinsulinemia, acting as a growth hormone that drives macrosomia (disproportionately large fetal size).

    • Delivery Risks: Gestational diabetics cannot deliver at home due to delivery complications, primarily shoulder dystocia (where the anterior fetal shoulder becomes lodged behind the maternal symphysis pubis).

    • Neonatal Risks: Following delivery, the neonate is at high risk for acute hypoglycemia because the high maternal glucose supply abruptly terminates while neonatal hyperinsulinemia persists.

  • Vena Cava Syndrome (Supine Hypotensive Syndrome):

    • Mechanism: Occurs when a pregnant client lies flat on their back (supine position). The heavy gravid uterus compresses the inferior vena cava and descending aorta against the spine, impairing venous return to the maternal heart.

    • Clinical Manifestations: Acute maternal hypotension, dizziness, pallor, cold clamminess, and lightheadedness.

    • Nursing Intervention: Position the client immediately in a left lateral tilt/decubitus position. This shifts uterine weight off the great vessels, restoring cardiac preload, maternal cardiac output, and uteroplacental blood flow.

Clinical Calculations, Rules, and Fetal Milestones

  • Naegele's Rule for Calculating Due Dates (Estimated Date of Confinement [EDC]):

    • Standard clinical formula based on a regular 28-day28\text{-day} menstrual cycle:         EDC=First day of Last Menstrual Period (LMP)−3 months+7 days+1 year\text{EDC} = \text{First day of Last Menstrual Period (LMP)} - 3\text{ months} + 7\text{ days} + 1\text{ year}

    • Alternative calculation adding elapsed time:         EDC=First day of LMP+7 days+9 months\text{EDC} = \text{First day of LMP} + 7\text{ days} + 9\text{ months}

    • Calculation Example: If the first day of the LMP is November 11 (November 1\text{November } 1):

      • Subtract 3 months3\text{ months}: August 11.

      • Add 7 days7\text{ days}: August 88.

      • Add 1 year1\text{ year}: August 88 of the following calendar year.

  • Obstetric History Notation (Gravida and Para / GTPAL):

    • Gravida (G): Total number of times a female has been pregnant, regardless of pregnancy outcome or plurality.

    • Para (P): Number of pregnancies reaching fetal viability (traditionally reaching at least 20 weeks20\text{ weeks} of gestation), regardless of whether the fetus is born alive or stillborn.

      • Scenario 1: A client documented as Gravida 11, Para 22 (G1P2\text{G}_1\text{P}_2) carried one multi-gestational pregnancy (such as twins) past the point of viability.

      • Scenario 2: A client documented as Gravida 55, Para 00 (G5P0\text{G}_5\text{P}_0) has had five pregnancies with zero viable outcomes, indicating recurrent pregnancy loss or multiple miscarriages.

    • GTPAL System:

      • G: Gravidity (total pregnancies).

      • T: Term births (≥37 weeks\ge 37\text{ weeks} of gestation).

      • P: Preterm births (20 to 36 weeks and 6 days20\text{ to }36\text{ weeks and }6\text{ days} of gestation).

      • A: Abortions (spontaneous miscarriages or elective terminations occurring before 20 weeks20\text{ weeks}).

      • L: Living children (current count of living biological offspring).

  • Fundal Height Landmarks:

    • The fundus grows predictably throughout gestation, measured via tape in centimeters from the top of the symphysis pubis to the top of the uterine fundus.

    • At 20 weeks20\text{ weeks} of gestation, the uterine fundus should reach the level of the umbilicus, measuring approximately 20 cm20\,\text{cm}.

    • Critical gestational weeks requiring anatomical evaluation on clinical examinations include 1010, 1212, 1414, 1515, 1818, 2020, 2424, and 28 weeks28\text{ weeks}.

  • Amniotic Fluid Volume and Terminology:

    • Normal Amniotic Volume: Normal amniotic fluid at term ranges between 700 to 1000 mL700\text{ to }1000\,\text{mL} (or 800 to 1000 mL800\text{ to }1000\,\text{mL}).

    • Oligohydramnios: An abnormally low volume of amniotic fluid (<500 mL< 500\,\text{mL} or an Amniotic Fluid Index [AFI] <5 cm< 5\,\text{cm}), indicative of underlying fetal renal anomalies or compromised uteroplacental perfusion.

    • Polyhydramnios (Hydramnios): Excessive amniotic fluid accumulation (>2000 mL> 2000\,\text{mL} or an AFI >24 to 25 cm> 24\text{ to }25\,\text{cm}), associated with fetal gastrointestinal obstructions, neural tube defects, or maternal gestational diabetes.

  • Fetal Heart Rate (FHR) Parameters:

    • The baseline normal fetal heart rate across gestation ranges between 110 to 160 bpm110\text{ to }160\,\text{bpm}.

  • Milestones in Fetal Growth and Perception:

    • Organogenesis: The first 8 weeks8\text{ weeks} represent the most critical, vulnerable window for organ development and structural teratogenesis.

    • Ballottement: A clinical palpatory assessment technique performed during a sterile vaginal examination. The examiner gently taps the anterior lower uterine segment/cervix; the floating fetus floats upward and rebounds back to tap the examiner's finger, confirming an unengaged, floating presenting part.

    • Quickening: Maternal awareness of fetal movements starts between 16 to 20 weeks16\text{ to }20\text{ weeks} of gestation (commonly perceived around 18 to 20 weeks18\text{ to }20\text{ weeks} in primigravidas and slightly earlier in multigravidas).

Prenatal Diagnostics and Fetal Assessment Modalities

  • Nonstress Test (NST):

    • Procedure: External electronic fetal monitoring placed on the maternal abdomen to record baseline fetal heart rate, variability, and accelerations in response to spontaneous fetal movement over a 20 to 40-minute20\text{ to }40\text{-minute} window.

    • Reactive NST (Reassuring): Demonstrates normal baseline rate, moderate variability, and two or more accelerations peaking at least 15 bpm15\,\text{bpm} above baseline and lasting at least 15 seconds15\text{ seconds} (15×1515 \times 15 criteria) within a 20-minute20\text{-minute} timeframe.

    • Nonreactive NST (Non-Reassuring): Fails to produce the required heart rate accelerations over an extended 40-minute40\text{-minute} test period.

    • Interventions for a Sleepy/Nonreactive Fetus:

      • Maternal consumption of cold, iced water.

      • Administration of a high-glucose beverage/juice (if the mother is non-diabetic).

      • Maternal position change to stimulate fetal movement.

      • Application of an external vibroacoustic stimulator over the fetal head on the maternal abdomen.

  • Contraction Stress Test (CST):

    • Indicated following a persistent nonreactive NST to evaluate uteroplacental respiratory reserve during the stress of uterine contractions.

    • Uterine contractions are induced via low-dose intravenous Pitocin (oxytocin) infusion or maternal nipple stimulation.

    • Negative CST (Normal/Reassuring): Demonstrates no late decelerations or significant variable decelerations across a minimum of three contractions lasting at least 40 seconds40\text{ seconds} within a 10-minute10\text{-minute} period.

    • Positive CST (Abnormal/Non-Reassuring): Demonstrates persistent, late decelerations occurring with 50%50\% or more of the uterine contractions, signaling uteroplacental insufficiency.

  • Invasive Prenatal Genetic Testing:

    • Chorionic Villus Sampling (CVS):

      • Aspiration of placental trophoblast tissue evaluated for fetal chromosomal, metabolic, or DNA abnormalities.

      • Clinical Window: Performed between 10 and 13 weeks10\text{ and }13\text{ weeks} (up to 14 weeks14\text{ weeks}). It cannot be performed earlier than 10 weeks10\text{ weeks} of gestation due to risk of limb reduction defects.

    • Amniocentesis:

      • Transabdominal needle aspiration of amniotic fluid guided by ultrasound.

      • Clinical Window: Routinely performed between 15 and 20 weeks15\text{ and }20\text{ weeks} of gestation for genetic karyotyping, elevated alpha-fetoprotein screening, or later in pregnancy to assess fetal lung maturity.

      • Frequently recommended for advanced maternal age (geriatric pregnancy, defined as maternal age ≥35 years\ge 35\text{ years} at delivery).

    • General Genetic Screening: Can be initiated as early as 10 weeks10\text{ weeks} of gestation. The nurse must respect client autonomy; clients hold the right to refuse genetic screening, requiring non-judgmental education on the scope, limitations, and implications of testing.

  • Transvaginal Ultrasound Nursing Considerations:

    • Maintain client dignity by draping the pelvis and lower extremities with a privacy sheet.

    • Ensure infection control: Disinfect probe between uses and apply a clean, protective probe sheath.

    • Apply sterile acoustic lubricant to the probe cover.

    • Crucial Pre-Assessment: Verify whether the client has an active latex allergy prior to using latex-containing probe sheaths.

    • Client communication: Instruct the client to take slow deep breaths and consciously relax the pelvic floor muscles to reduce insertion pressure and discomfort.

  • Magnetic Resonance Imaging (MRI) Safety in Pregnancy:

    • Safe during pregnancy when medically justified, as it does not emit ionizing radiation.

    • All ferromagnetic metals, jewelry, and piercings must be removed prior to entry into the magnetic field.

    • Assess client claustrophobia and procedural anxiety; offer therapeutic support and inform the imaging team.

Infertility, Genetics, and Reproductive Anatomy

  • Etiologies and Diagnostics of Infertility:

    • Female Reproductive Factors:

      • Polycystic Ovary Syndrome (PCOS).

      • Endometriosis (aberrant endometrial tissue implantation).

      • Tubal occlusion or structural pelvic adhesions secondary to pelvic inflammatory disease (PID).

      • Premature ovarian failure/early menopause (manifesting as amenorrhea, vasomotor hot flashes; evaluated via serum gonadotropins and estrogen levels).

    • Male Reproductive Factors:

      • Low absolute sperm count (oligospermia) or absent sperm (azoospermia).

      • Impaired sperm motility (asthenospermia) or abnormal morphology (teratospermia).

      • Vasectomy reversal failure due to obstructive scar tissue or the development of antisperm antibodies.

      • Cryptorchidism (undescended testicles during childhood development resulting in impaired thermal regulation and spermatogenesis).

      • Inguinal hernias causing physical compression of reproductive ducts (assessed via scrotal palpation during coughing).

      • Antihypertensive medications, including ACE inhibitors, impairing spermatogenesis or erectile function.

    • Infertility Diagnostic Procedures:

      • Hysterosalpingography (HSG): Fluoroscopic X-ray imaging using radiopaque contrast dye injected transcervically to visualize the contour of the uterine cavity and confirm bilateral fallopian tube patency. Detects intracavitary lesions such as submucosal uterine fibroids, polyps, or tubal blockages.

      • Semen Analysis: Direct quantitative and qualitative laboratory examination of the ejaculate to measure volume, sperm concentration, motility, forward progression, and morphology.

  • Client Education for Optimizing Spermatogenesis:

    • Avoid scrotal hyperthermia: Wear loose-fitting cotton boxers rather than tight briefs; avoid saunas, hot tubs, and laptop placement on the lap.

    • Smoking cessation and abstinence from heavy alcohol intake.

    • Maintain a balanced, nutrient-dense diet avoiding ultra-processed foods.

    • Engage in regular moderate physical exercise and stress reduction practices (mindfulness/meditation).

  • Anatomical STI Vulnerability Differences:

    • Females possess a short urethra and immediate proximity to the vaginal vault, leading to earlier clinical symptoms of urinary and reproductive tract irritation (dysuria, pruritus, discharge).

    • Males possess a substantially longer penile urethra; sexually transmitted pathogens (e.g., Chlamydia trachomatis, Neisseria gonorrhoeae) can remain asymptomatic and subclinical for years, leading to silent reproductive tract scarring, epididymitis, and secondary infertility.

  • Sickle Cell Disease Inheritance Patterns:

    • Autosomal recessive hemoglobinopathy predominantly affecting populations of African ancestry.

    • Both biological parents must carry the mutated sickle cell gene for offspring to manifest the disease.

    • If both parents possess the sickle cell trait (heterozygous carriers):

      • 25%25\% chance of offspring inheriting two normal alleles (unaffected non-carrier).

      • 50%50\% chance of offspring inheriting one mutant allele (asymptomatic carrier with sickle cell trait).

      • 25%25\% chance of offspring inheriting two mutant alleles (clinically affected with sickle cell disease).

  • Physiological Functions of Amniotic Fluid:

    • Cushioning and Protection: Acts as a hydraulic shock absorber shielding the fetus against maternal abdominal blunt trauma.

    • Thermal Regulation: Maintains a stable, constant intra-amniotic ambient temperature.

    • Skeletal and Muscular Development: Permits symmetrical, buoyant fetal movement, preventing congenital contractures and amniotic band constrictions.

    • Umbilical Cord Protection: Prevents physical compression of the umbilical cord vessels during contractions and movements.

    • Index of Fetal Renal Function: Swallowed amniotic fluid is excreted by functional fetal kidneys; volume directly reflects fetal renal blood flow and urinary output.

  • Fetal Circulation Structures and Pathways:

    • Fetal circulatory physiology relies on specific anatomical vascular shunts that bypass non-functioning fetal lungs and metabolizing liver, carrying oxygenated blood from the placenta:

      • Umbilical Vein: Carries oxygenated, nutrient-rich blood from the placenta to the fetus.

      • Ductus Venosus: Shunts a significant portion of oxygenated umbilical venous blood past the fetal liver directly into the inferior vena cava.

      • Foramen Ovale: An anatomical flap-valve opening between the right atrium and left atrium, allowing oxygenated blood to bypass the right ventricle and pulmonary circuit.

      • Ductus Arteriosus: A vascular connection between the pulmonary artery and descending aorta, diverting deoxygenated blood away from the pulmonary vascular bed into systemic circulation.

      • Umbilical Arteries (2): Carry deoxygenated blood and metabolic waste products from the fetal internal iliac arteries back to the placenta for maternal clearance.

Pharmacology and Teratogenic Substances in Pregnancy

  • Teratogenic Mechanisms and Critical Windows:

    • A teratogen is an environmental agent, drug, or chemical capable of inducing structural, functional, or behavioral birth defects following maternal exposure during intrauterine development.

    • The highest risk for catastrophic structural organ malformations occurs during embryonic organogenesis, spanning weeks 3 through 83\text{ through }8 (8 weeks8\text{ weeks} total) after conception.

  • Known Teratogenic Medications and Adverse Fetal Outcomes:

    • Retinoids (Retin-A / Isotretinoin): Severe craniofacial, cardiac, thymic, and central nervous system defects. Mandates enrolled participation in risk management programs requiring documented negative pregnancy tests and two concurrent forms of contraception.

    • Lithium: Strongly associated with severe cardiovascular malformations, historically documented as Ebstein's anomaly (transcript colloquially references Epstein-Barr association).

    • Angiotensin-Converting Enzyme (ACE) Inhibitors & ARBs: Cause fetal renal dysgenesis, severe oligohydramnios, pulmonary hypoplasia, and neonatal renal failure.

    • Warfarin: Readily crosses the placental barrier causing fetal warfarin syndrome (chondrodysplasia punctata, nasal hypoplasia, optic atrophy, microcephaly).

    • Anticonvulsants (Carbamazepine, Phenytoin, Phenobarbital): Induce fetal hydantoin syndrome, neural tube defects (spina bifida), microcephaly, and cardiac anomalies.

    • Methotrexate: High-potency folic acid antagonist leading to spontaneous abortion, severe skeletal defects, and cranial dysmorphism.

    • Statins (HMG-CoA Reductase Inhibitors): Disruption of essential fetal cholesterol synthesis pathways.

    • Amphotericin B: Broad systemic toxicity profile with marked maternal-fetal physiologic stress.

    • Beta-Blockers: Associated with intrauterine fetal growth restriction (IUGR), neonatal bradycardia, and neonatal hypoglycemia.

  • Psychotropics in Pregnancy:

    • Most psychotropics carry documented perinatal risks.

    • Sertraline: Frequently preferred and selected as a primary, well-studied Selective Serotonin Reuptake Inhibitor (SSRI) with established clinical use during pregnancy.

  • Neural Tube Defect Prevention with Folic Acid:

    • Folic acid supplementation is mandatory prior to conception and throughout the first trimester to ensure complete closure of the neural tube (brain and spinal cord develop in early gestation).

    • Transcript slip: "Phosphoric acid" was mistakenly vocalized by a participant; the correct physiological nutrient is folic acid (vitamin B9B_9).

  • Oxytocin and Uterine Dynamics:

    • Endogenous Oxytocin: Posterior pituitary hormone released via neuroendocrine reflexes (such as manual nipple stimulation), stimulating myometrial uterine contractions.

    • Pitocin: Synthetic commercial equivalent of oxytocin administered intravenously for the pharmacological induction or augmentation of labor, as well as the prevention and management of postpartum hemorrhage.

Labor, Delivery, and Postpartum Nursing Care

  • Premature Rupture of Membranes (PROM):

    • The rupture of the amniotic sac prior to the onset of true labor.

    • Primary Risk: Ascending intrauterine infection (chorioamnionitis, neonatal sepsis). Delivery is targeted within 24 hours24\text{ hours} of membrane rupture to mitigate infection.

    • Meconium-Stained Amniotic Fluid: Occurs when the fetus passes meconium in utero due to maturity or transient hypoxia. It warrants close fetal heart rate monitoring and resuscitation readiness, but does not necessitate an immediate emergency cesarean section in the absence of acute non-reassuring fetal status.

    • Elective Induction Thresholds: Elective labor induction without medical indication is prohibited prior to 39 weeks39\text{ weeks} of gestation (39 weeks39\text{ weeks} standard, or medically indicated by 38 weeks38\text{ weeks}).

  • Uterine Irritability and Hydration:

    • Maternal dehydration is a primary trigger for premature uterine cramping and contractions due to hemoconcentration and antidiuretic hormone/oxytocin release from the posterior pituitary.

    • The primary initial nursing intervention for non-labor contractions is aggressive intravenous or oral hydration.

  • Braxton Hicks Contractions versus True Labor:

    • Braxton Hicks Contractions: Intermittent, irregular, painless or uncomfortable uterine tightenings that do not increase in frequency, duration, or intensity. They do not produce progressive cervical effacement or dilation.

    • True Labor Contractions: Regular, progressively strengthening contractions that radiate from the lumbosacral back to the anterior abdomen, becoming closer together and resulting in cervical change.

  • Maternal Laboratory Parameters in Pregnancy:

    • Hemoglobin Reference Range: Normal maternal hemoglobin is between 12 to 15 g/dL12\text{ to }15\,\text{g/dL}.

    • Anemia Threshold: Maternal hemoglobin dropping below 10 g/dL10\,\text{g/dL} (or severely below 9 g/dL9\,\text{g/dL}) confirms clinically significant anemia.

    • Clinical Signs of Anemia: Chronic fatigue, cold intolerance/chills, exertional dyspnea, pallor, hypotension, and pica (compulsive consumption of non-nutritive substances, such as pagophagia/ice eating).

    • Physiologic Hemodilution & Heart Rate: Maternal plasma volume expands by 40 to 50%40\text{ to }50\% while erythrocyte mass expands by only 20 to 30%20\text{ to }30\%, causing physiologic hemodilution (pseudoanemia). A mild maternal baseline heart rate elevation (e.g., from an un-pregnant resting rate of 70 bpm70\,\text{bpm} up to 90 bpm90\,\text{bpm}) is a normal physiologic adaptation to increased stroke volume and cardiac output.

  • Rubin's Phases of Maternal Psychological Adaptation:

    • The developmental and emotional tasks an expectant mother navigates during pregnancy:

      1. Ensuring Safe Passage: Seeking competent medical care, adhering to healthy behaviors, and protecting self and infant through labor and birth.

      2. Ensuring Social Acceptance: Working to integrate the forthcoming infant into the family unit and securing acceptance from the father/significant others.

      3. Binding-in (Expressing Attachment): Developing a profound emotional attachment, bonding with the unborn fetus, and integrating the maternal role into self-identity.

      4. Giving of Oneself: Cultivating an unconditional willingness to sacrifice personal needs and comfort on behalf of the child's well-being.

  • Couvade Syndrome (Sympathetic Pregnancy):

    • A psychosomatic condition wherein an expectant father/partner exhibits pregnancy-related signs and symptoms alongside the pregnant partner.

    • Common Symptoms: Involuntary weight gain, nausea/morning sickness, altered appetite, gastrointestinal bloating, backaches, extreme fatigue, and emotional lability.

  • Nesting Phenomenon:

    • A sudden surge of maternal energy observed in late third trimester, characterized by compulsive house cleaning, organizing the nursery, and finalizing physical preparations for the infant's birth.

  • Clinical Management of Hemorrhoids:

    • Dietary modifications: Increase high-fiber foods and daily oral fluid intake to soften stools and eliminate maternal straining.

    • Topical analgesia: Witch hazel pads (Tucks pads), hydrocortisone-based creams, or Preparation H.

    • Stool softeners: Polyethylene glycol (Miralax) or docusate sodium.

    • Cryotherapy: Direct application of ice packs to reduce vascular engorgement and tissue edema (avoid warm heat, which causes local vasodilation and exacerbates acute swelling).

  • Nutritional Sources for Prenatal Health:

    • Dietary Dairy: Whole milk, hard cheeses, yogurt (rich in calcium and vitamin D).

    • Dietary Starches: Potatoes, corn, whole grains, complex carbohydrates.

    • Natural Sugars: Fresh fruits (fructose).

    • High-Iron Sources: Dark green leafy vegetables (spinach, kale), broccoli, raspberries, fortified grains, and red meat.

  • Home Birth Preparedness:

    • Requires a qualified, trained delivery team (certified nurse-midwife, trained delivery assistant, or paramedic standby).

    • Essential medical equipment: Sterile cord-clamping scissors, umbilical clamps, bulb suction syringe for airway clearance, neonatal resuscitation bag-and-mask, oxygen supplies, and an emergency transfer plan to a hospital.

Questions, Course Logistics, and Exam Preparation

  • Review Video Durations and Priorities:

    • Pharmacology review video: 3 minutes3\text{ minutes}.

    • Gravida/Para video: 7 minutes7\text{ minutes}.

    • GTPAL review video: 5 minutes5\text{ minutes}.

  • Examination Structure and Scoring:

    • Total exam items: 50 questions50\text{ questions}.

    • Specific question formats: Includes 1 fill-in-the-blank1\text{ fill-in-the-blank} question, 1 hotspot/diagram1\text{ hotspot/diagram} question ("find the fundus"), and 6 Select All That Apply (SATA)6\text{ Select All That Apply (SATA)} questions.

    • Dosage calculation questions: None present on this specific examination.

    • Academic grading standard: Minimum passing score threshold is 78%78\% (with discussions regarding 80%80\% grade requirements for graduate nurse practitioner cohorts).

  • Study Group Cohort Discussion:

    • Student Query on Shadow Health Integration: Students noted confusion accessing the correct Shadow Health class section, identifying that sections from prior terms (25262526 / Sam Resica) were mistakenly entered. Students were redirected to scroll down and register for the current active course section led by Ms. Chandler Rios.

    • Course Instruction Comparison: Dialogue regarding differing pedagogical structures across classes. In pediatric nursing (taught by Reeves), lecture slides directed students to read extensive textbook assignments (11 chapters11\text{ chapters}) without structured interactive reviews. Students contrasted this with exam topic reviews addressing signs, symptoms, and pathology without giving verbatim answers.

    • Faculty Transitions and Academic Milestones: Discussions regarding faculty assignments, including Dr. Walker's current involvement in the transition program, Dr. Abert's hidden lecture recordings, and plans for the Doctor of Nursing Practice (DNP) cohort meeting in Waco on the 20th20\text{th} for the Baylor versus Texas Tech football game.